When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Granuloma annulare

Evidence last reviewed: 18 Jun 2026
Topic last updated: 14 Jul 2026

Summary

Definition

History and exam

Key diagnostic factors

  • asymptomatic grouped annular pink or flesh-colored dermal papules
Full details

Other diagnostic factors

  • flesh-colored, pink, or brown macules or small papules
  • soft-tissue nodules
  • perforating papules, crusting or ulcerated lesions
  • erythematous patches
Full details

Risk factors

  • diabetes mellitus
  • hematologic malignancy
  • herpes zoster
  • HIV
  • hepatitis
  • hyperlipidemia
  • thyroid disease
  • drugs
Full details

Diagnostic tests

1st tests to order

  • clinical diagnosis
Full details

Tests to consider

  • skin biopsy
  • fasting blood sugar
  • thyroid function tests
  • lipid screening
  • hepatitis serology
  • HIV testing
Full details

Treatment algorithm

ACUTE

localized variant (classic annular rash)

generalized variant (widespread macular rash)

subcutaneous variant (soft nodule)

patch variant (erythematous plaques)

perforating variant (crusted or ulcerated lesion)

Contributors

Authors

Misha Rosenbach, MD

Professor

Dermatology and Internal Medicine (Rheumatology)

University of Pennsylvania

Philadelphia, PA

Disclosures

MR has received consulting fees from Merck, Johnson & Johnson, Novartis, and Processa Pharma, not related to granuloma annulare.

Acknowledgements

Dr Misha Rosenbach would like to gratefully acknowledge Dr Susmita Mukherjee, a previous contributor to this topic.

Disclosures

SM declares that she has no competing interests.

Peer reviewers

Aisha Sethi, MD

Assistant Professor of Medicine

Associate Residency Program Director

University of Chicago

Chicago

IL

Disclosures

AS declares that she has no competing interests.

Robert Herd, MSc, MD, FRCP

Consultant Dermatologist

Department of Dermatology

Nuffield Hospital

Glasgow

UK

Disclosures

RH declares that he has no competing interests.

Brenda L. Pellicane, MD

Dermatologist

Wayne State University School of Medicine

Department of Dermatology

Detroit, MI

Disclosures

BLP declares that she has no competing interests.

Peer reviewer acknowledgements

BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.

Disclosures

Peer reviewer affiliations and disclosures pertain to the time of the review.

References

Our in-house evidence and editorial teams collaborate with international expert contributors and peer reviewers to ensure that we provide access to the most clinically relevant information possible.

Key articles

Piette EW, Rosenbach M. Granuloma annulare: clinical and histologic variants, epidemiology, and genetics. J Am Acad Dermatol. 2016 Sep;75(3):457-65. Abstract

Kachlik Z, Kaczmarek A, Grych K. et al. Granuloma annulare: a clinical update. Curr Derm Rep. 2024 May 22;13:183-97.Full text

Piette EW, Rosenbach M. Granuloma annulare: pathogenesis, disease associations and triggers, and therapeutic options. J Am Acad Dermatol. 2016 Sep;75(3):467-79. Abstract

Wang J, Khachemoune A. Granuloma annulare: a focused review of therapeutic options. Am J Clin Dermatol. 2018 Jun;19(3):333-44. Abstract

Reference articles

A full list of sources referenced in this topic is available to users with access to all of BMJ Best Practice.

Use of this content is subject to our disclaimer